How COVID-19 pandemic is shaping our preparations in India for the next pandemic by Emerging and Reemerging infectious diseases: A Review: How COVID-19 pandemic is shaping our preparations in India for the next pandemic by Emerging and Reemerging infectious diseases: A Review

Nikunja Das; Sandhya Kulkarni; Sadhana Chate

Authors

Nikunja Das Department of Microbiology, MAEER MIT Pune’s MIMER Medical College & Dr. BSTR Hospital, Talegaon (D), Pune- 410507
Sandhya Kulkarni Principal, MAEER MIT Pune’s MIMER Medical College & Dr. BSTR Hospital, Talegaon (D), Pune- 410507
Sadhana Chate Department of Microbiology, MAEER MIT Pune’s MIMER Medical College & Dr. BSTR Hospital, Talegaon (D), Pune- 410507

Keywords:

Emerging, Reemerging, Pandemic, Covid-19

Abstract

Emerging infectious diseases are those which have been newly identified in a population, have existed before but now increasing rapidly in incidence or geographical location. Remerging infectious disease are those infections which were a problem in the past, but then declined and now they are again increasing in incidence due to various factors. Emerging infections of interest are SARS, COVID-19, Nipah, Bartonellosis, Lyme’s disease, Cryptosporidiosis etc. Examples of some reemerging infections are West Nile fever, Dengue, Tuberculosis, Malaria, Ebola, Cholera, Plague. For COVID-19, a pandemic which appeared all of a sudden but in a distant land, gave some space for preparedness. The challenges associated with a novel or emerging infection is lack of diagnostic kits, trained personnel at grassroot levels to use the newly developed tests. India which was placed at rank of 57 in Global health security index fared much better than countries placed in top 5. India has had a very successful implementation of vaccination program in the past. That experience and infrastructure with trained personnel play a huge role in implementation of COVID-19 vaccination

References

Kant L. Combating emerging infectious diseases in India: orchestrating a symphony. J Biosci. 2008;33(4):425-7. doi: 10.1007/s12038-008-0061-4. PMID: 19208968; PMCID: PMC7090458.

Spernovasilis N, Tsiodras S, Poulakou G. Emerging and Re-Emerging Infectious Diseases: Humankind's Companions and Competitors. Microorganisms. 2022;10(1):98. doi: 10.3390/microorganisms10010098. PMID: 35056547; PMCID: PMC8780145.

Tabish S.A. Recent trends in emerging infectious diseases. Int. J. Health Sci. 2009;3:V–VIII.

Wang WH, Thitithanyanont A, Urbina AN, Wang SF. Emerging and Re-Emerging Diseases. Pathogens. 2021;10(7):827. doi: 10.3390/pathogens10070827. PMID: 34209374; PMCID: PMC8308756.

Dikid T, Jain SK, Sharma A, Kumar A, Narain JP. Emerging & re-emerging infections in India: an overview. Indian J Med Res. 2013;138(1):19-31. PMID: 24056553; PMCID: PMC3767269.

Morens DM, Fauci AS. Emerging Pandemic Diseases: How We Got to COVID-19. Cell. 2020;182(5):1077-1092. doi: 10.1016/j.cell.2020.08.021. Epub 2020 Aug 15. Erratum in: Cell. 2020 Oct 29;183(3):837. PMID: 32846157; PMCID: PMC7428724.

Covid-19 Impacts and responses: The Indian experience. Available from https://ndma.gov.in/sites/default/files/pdf/covid/Covid-19/indi . Last assessed on 18.10.2023.

Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol. 2021;105(2):441-455. doi: 10.1007/s00253-020-11061-5. Epub 2021 Jan 4. PMID: 33394144; PMCID: PMC7780074.

How India scaled up its laboratory testing capacity for COVID-19. Available from https://www.who.int/india/news/feature-stoi. Last assessed on 19.10.2023.

Mukhida S, Khan S, Das NK, Patil R, Vyawahare C. How long time to learn lessons and move on from pandemic? Med J Dr. D.Y. Patil Vidyapeeth 2022;15(6):960

Tyagi A, Prasad AK, Bhatia D. Effects of excessive use of mobile phone technology in India on human health during COVID-19 lockdown. Technol Soc. 2021 Nov;67:101762. doi: 10.1016/j.techsoc.2021.101762. Epub 2021 Sep 22. PMID: 34566205; PMCID: PMC8456111.

Ratan ZA, Zaman SB, Islam SMS, Hosseinzadeh H. Smartphone overuse: A hidden crisis in COVID-19. Health Policy Technol. 2021 Mar;10(1):21-22. doi: 10.1016/j.hlpt.2021.01.002. Epub 2021 Jan 23. PMID: 33520635; PMCID: PMC7825859.

Hodinka RL. Point: is the era of viral culture over in the clinical microbiology laboratory? J Clin Microbiol. 2013 Jan;51(1):2-4. doi: 10.1128/JCM.02593-12. Epub 2012 Oct 10. PMID: 23052302; PMCID: PMC3536207.

Kaltenboeck B, Wang C. Advances in real-time PCR: application to clinical laboratory diagnostics. Adv Clin Chem. 2005;40:219-59. doi: 10.1016/s0065-2423(05)40006-2. PMID: 16355924; PMCID: PMC7112074.

Padmanabhan A. How aadhaar showed the way for India’s gargantuan Covid vaccination drive. Available from https://economictimes.indiatimes.com/opinion/et-commentaryhow-aad . Last accessed on 25.10.23

Yagnik B. BSL-2 labs mandatory for medical colleges: MCI. Available from www.https://timesofindia.indiatimes.com/city/ahmedabad/bsl-2-labs. Last assessed on 27.10.2023.

Babu GR, Ray D, Bhaduri R, Halder A, Kundu R, Menon GI, Mukherjee B. COVID-19 Pandemic in India: Through the Lens of Modeling. Glob Health Sci Pract. 2021 Jun 30;9(2):220-228. doi: 10.9745/GHSP-D-21-00233.

Press Information Bureau Delhi. Updates on COVID-19. April17, 2020. Accessed May 13, 2021. https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1615405

Mirza M, Verma M, Sahoo SS, Roy S, Kakkar R, Singh DK. India's Multi-Sectoral Response to Oxygen Surge Demand during COVID-19 Pandemic: A Scoping Review. Indian J Community Med. 2023;48(1):31-40. doi: 10.4103/ijcm.ijcm_665_22.

Mukhida S, Vyawahare C, Verma P, Khan S, Das NK. Are the current Covid-19 cases post phase of 3rd wave or pre-phase of 4th wave in India? Iranian J Med Micro 2023;17(2):270-2

Das NK, Prasanna S, Pandit P, Dudhat VL. How much can we rely on a scrambled COVID-19 vaccine? It is not the only way out! Med J Dr. D.Y. Patil Vidyapeeth 2022;15:353-5

Mukhida S, Kannuri S, Das NK, Khan S, Patil R. Is a Vaccine One of the Factors that Will Contribute to the End of the Pandemic? Iranian J Med Micro. 2023;17(3):377-8

Desai D, Das NK, Mukhida S, Paranjpe R. Is India Quietly Becoming a Favourable Hub for Clinical Trials? Natl J Community Med. 2023;14(09):626-7.

Gasmi A, Peana M, Noor S, Lysiuk R, Menzel A, Gasmi Benahmed A, Bjørklund G. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story. Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30. PMID: 33515285; PMCID: PMC7847229.

Xu S, Ding D, Zhang X, Sun L, Kang D, Huang B, Liu X, Zhan P. Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary. Molecules. 2022 Jan 27;27(3):850. doi: 10.3390/molecules27030850. PMID: 35164129; PMCID: PMC8839652.

Aleem A, Vaqar S. Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations. 2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 34033365

How COVID-19 pandemic is shaping our preparations in India for the next pandemic by Emerging and Reemerging infectious diseases: A Review